Showing results (121-130 of 129) with videos related to
Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Integrative Cancer Therapies|January 1, 2010
Making circadian cancer therapy practicalKeith I Block, Penny B Block, Susan Reynolds Fox, et al.Journal of Developmental Origins of Health and Disease|August 8, 2014
Altered expression and chromatin structure of the hippocampal IGF1r gene is associated with impaired hippocampal function in the adult IUGR male ratD Caprau, M E Schober, K Bass, et al.Annals of Internal Medicine|February 1, 1984
Clinical staging for cutaneous T-cell lymphomaS I Lamberg, S B Green, D P Byar, et al.Bioorganic & Medicinal Chemistry Letters|January 1, 1999
New generation dopaminergic agents. 2. Discovery of 3-OH-phenoxyethylamine and 3-OH-N1-phenylpiperazine dopaminergic templatesR E Mewshaw, M Husbands, E S Gildersleeve, et al.Journal of Medicinal Chemistry|May 1, 1979
Syntheses, analgetic activity, and physical dependence capacity of 5-phenyl-6,7-benzomorphan derivativesN Yokoyama, P I Almaula, F B Block, et al.Cancer Treatment Reports|April 1, 1979
Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative GroupS I Lamberg, S B Green, D P Byar, et al.Journal of Medicinal Chemistry|January 22, 1998
New generation dopaminergic agents. 1. Discovery of a novel scaffold which embraces the D2 agonist pharmacophore. Structure-activity relationships of a series of 2-(aminomethyl)chromansR E Mewshaw, J Kavanagh, G Stack, et al.Science Translational Medicine|June 4, 2025
A phase 1 clinical trial shows safe, sustained, AAV-mediated expression of IL-1Ra in the human osteoarthritic knee jointRodolfo E De la Vega, Jacob L Sellon, Jay Smith, et al.Seminars in Cancer Biology|November 23, 2015
Designing a broad-spectrum integrative approach for cancer prevention and treatmentKeith I Block, Charlotte Gyllenhaal, Leroy Lowe, et al.Pageof 13